Increasing Product Launches are Propelling the Growth of the Robotic Surgery For Endometrial Cancer Market in the APAC Region!

Asia-Pacific held a considerable market share in 2022 with a share of 15.2% and is expected to grow with the highest CAGR of 16.3% in the global robotic surgery for endometrial cancer market. The market growth in this region is attributed to factors such as an increasing prevalence of endometrial cancer, rising awareness of robotic surgical options, improvements in healthcare infrastructure, and the adoption of advanced medical technologies. Furthermore, the region is also witnessing rapidly increasing cases of uterine cancer is also a major important factor in the market growth of robotic surgery for endometrial cancer in the Asia-Pacific. For example, according to Globocan 2020, 167,310 new cases of corpus uteri were registered in Asia. Additionally, the increasing focus on technological advancements in the medical sector, along with the integration of robotic systems in the region is the major reason contributing to the growth of the market.

Access sample report (including graphs, charts, and figures) – https://univdatos.com/get-a-free-sample-form-php/?product_id=45494

Further, the Asia-Pacific Robotic Surgery For Endometrial Cancer Market is expected to grow at a strong CAGR of 16% during the forecast period (2023-2030). The growing geriatric population and rising advancements in surgical technology among them are the major reason for the market growth of Robotic Surgery For Endometrial Cancer in the Asia-Pacific.

FIG. 1 APAC Robotic Surgery For Endometrial Cancer Market Revenue (2020-2030)- USD Mn

Based on components, the market is segmented into robotic surgery systems and maintenance services. Robotic surgery systems dominated the market in 2022. Robotic surgery is relatively a newer approach in the medical industry and the demand for robotic systems is high which is the responsible factor for the large share of robotic systems in endometrial cancer surgeries.

Based on surgery type, the market is segmented into cryosurgery, laser surgery, hysterectomy, and others. The hysterectomy category is expected to witness the fastest growth during the forecast period. Hysterectomy is a surgical procedure that involves the removal of the uterus. A hysterectomy is a common that is performed by robotic systems in case of uterine cancer. The hysterectomy is a less complex surgery that can be performed by robotic systems easily which is an important reason for the largest share of the segment.

On the basis of end-users, the market is categorized into hospitals & clinics, research centers, and others. Among these, the hospitals & clinics category held a significant share of the market in 2022. This is mainly due to the rising number of cancer cases, along with the increasing hospitalization are the major factors responsible for the segmental growth of the hospitals.

For a detailed analysis of Global Robotic Surgery For Endometrial Cancer Market browse through – https://univdatos.com/report/robotic-surgery-for-endometrial-cancer-market/

Global Robotic Surgery for Endometrial Cancer Market Segmentation

Market Insight, by Components

· Robotic Surgery System

· Maintenance Service

Market Insight, by Surgery Type

· Cryosurgery

· Laser Surgery

· Hysterectomy

· Others

Market Insight, by End-User

· Hospitals & Clinics

· Research Centers

· Others

Market Insight, by Region

· North America

o U.S.

o Canada

o Rest of North America

· Europe

o Germany

o UK

o France

o Italy

o Spain

o Rest of Europe

· APAC

o China

o Japan

o India

o Rest of APAC

· Rest of the World

Top Company Profiles

· Intuitive Surgical

· Stryker

· Accuray Incorporated

· NuVasive, Inc

· Smith+Nephew

· Asensus Surgical US, Inc.

· Medtronic

· Auris Health, Inc.

· Siemens Healthcare GmbH

· Renishaw plc.